ST
AMED

Smithfield Trust’s Amedisys AMED Stock Holding History

Smithfield Trust’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-147
Closed -$22K – 1070
2021
Q3 		$22K Hold
147
– – ﹤0.01% 693
2021
Q2 		$36K Hold
147
– – ﹤0.01% 600
2021
Q1 		$39K Hold
147
– – ﹤0.01% 592
2020
Q4 		$43K Hold
147
– – ﹤0.01% 551
2020
Q3 		$35K Hold
147
– – ﹤0.01% 562
2020
Q2 		$29K Hold
147
– – ﹤0.01% 564
2020
Q1 		$27K Buy
+147
New +$26.2K ﹤0.01% 523

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Smithfield Trust's AMED Position: Q4 2021 in Review

Smithfield Trust sold out of Amedisys (AMED) in Q4 2021, closing a stake of 147 shares — an estimated $22K sold.

Smithfield Trust first reported a position in AMED in Q1 2020 and held it in 7 quarters. The position peaked at $43K in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Smithfield Trust reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Smithfield Trust sold 147 Amedisys shares in Q4 2021, an estimated $22K.
  • Smithfield Trust first reported a position in Amedisys in Q1 2020 and held it in 7 quarters.
  • Smithfield Trust's Amedisys position peaked at $43K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Smithfield Trust's 13F filing for Q4 2021, filed 14 Feb 2022.